Hagar Ibrahim Labouta

Title: Hagar Ibrahim Labouta: Innovator in Drug Targeting Systems

Introduction

Hagar Ibrahim Labouta is a notable inventor based in Calgary, Canada. He has made significant contributions to the field of drug delivery systems, particularly through his innovative approaches to intracellular drug targeting. His work focuses on enhancing the efficacy of pharmaceutical compositions by utilizing advanced carrier systems.

Latest Patents

Hagar Ibrahim Labouta holds 1 patent for his invention titled "Methods and compositions of carrier systems for the purpose of intracellular drug targeting." This patent describes a carrier system that includes a pathogen entry protein or fragment that specifically binds to a molecule on the surface of a mammalian target cell. The carrier is covalently linked to the surface of the carrier and at least one hydrophilic antipathogenic agent. The invention also outlines a method for manufacturing this carrier system and its application as a medicament.

Career Highlights

Hagar is currently associated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he continues to advance his research in drug delivery systems. His work is pivotal in developing new therapeutic strategies that can improve patient outcomes.

Collaborations

Hagar collaborates with esteemed colleagues, including Claus-Michael Lehr and Sarah Gordon, who contribute to his research endeavors and enhance the impact of his innovations.

Conclusion

Hagar Ibrahim Labouta is a pioneering inventor whose work in drug targeting systems is shaping the future of pharmaceutical science. His innovative approaches and collaborations are paving the way for more effective treatments.